MPP

Capital Vitality Voted Best Pharma Product 2027

Actualité & presse

Capital Vitalité élu Meilleur Produit Pharma 2027

Longevity®’s Capital Vitality won the Best Pharma Product 2027 award in the Concentration and Vitality category. Awarded following a test conducted with more than 100 consumers, this distinction placed the product at the top of its category. It is a strong recognition of consumers’ positive perception of its benefits.

La rédaction Longevity

Mis à jour le 18 November 2026
4 min de lecture
MPP

A prestigious award in the pharmaceutical industry

Each year, the Best Pharma Product awards recognize the products most highly rated by a panel of 100 consumers. The principle is simple: products are tested by consumers, who assess them according to several criteria, including perceived effectiveness, ease of use, overall experience and purchase intent.

For the 2027 edition, Capital Vitality achieved the highest score in the Concentration and Vitality category. This award provides strong evidence of consumer satisfaction and is a valuable indicator of the product’s perceived quality.


A formula that targets the visible and invisible signs of aging and meets consumer expectations

The evaluation results highlight a high level of satisfaction and consumer engagement.

Strong purchase intent

After testing the product, 66% of consumers said they intended to purchase Capital Vitality in the near future.

A very high recommendation rate
83% of respondents said they would recommend the product to friends and family.

An excellent first impression
On discovering the product, 83% of participants reported a positive first impression.


Perceived benefits for daily energy and well-being

Beyond the figures, the testimonials collected during the study provide concrete insight into the consumer experience.

Several participants reported a gradual and lasting boost in energy:

“After a few days, I felt a real boost in energy and, above all, noticeably less fatigue throughout the day. I also found that my concentration was better and that I recovered more easily.”

Others highlighted an improvement in their overall vitality:

“I started feeling the benefits after a week. I feel more energetic, more focused and less stressed.”

Some consumers experiencing recurring fatigue associated with age or specific periods of life also particularly appreciated the benefits:

“I noticed a difference in my morning energy levels and the afternoon slumps.”

Ease of use was also frequently mentioned as a source of satisfaction:

“The tablets are easy to swallow, have no taste and fit easily into my daily routine.”

Finally, some testimonials expressed particularly strong enthusiasm:

“I feel fitter, better in myself and more motivated to get moving.”

“An exceptional product for regaining great vitality!”


Recognition that reinforces the Longevity® vision

Winning the Best Pharma Product 2027 award marks an important milestone in the brand’s development. Beyond the award itself, this distinction reflects the ability of an innovative product to meet consumers’ expectations in practical terms.

It also reinforces the relevance of an approach designed to support the visible and invisible signs of aging, with a focus on vitality and overall well-being.


In summary

  • Best Pharma Product 2027 award in the Concentration and Vitality category
  • Highest score in its category
  • 66% purchase intent after testing
  • 83% of consumers would recommend the product
  • 83% positive first impressions
  • A formula that targets visible and invisible signs of aging by combining vitality with support for healthy aging